• Explore /
  • Poster
  • / Effect of imprime PGG on innate immune-activating pharmacodynamic changes in a phase I clinical study in healthy human volunteers.

Effect of imprime PGG on innate immune-activating pharmacodynamic changes in a phase I clinical study in healthy human volunteers.

Abstract Poster

Authors

Nandita Bose

Nandita Bose

Biothera Pharmaceutical, Inc., Eagan, MN

Nandita Bose, Nadine Ottoson, Ben Harrison, Jamie R. Lowe, Mark Matson, Xiaohong Qiu, Adria Bykowski Jonas, Blaine Rathmann, Takashi Kangas, Lindsay R. Wurst, Anissa S.H. Chan, Kathryn Fraser, Richard Walsh, Katie E. Ertelt, Steven Leonardo, Ross Fulton, Keith Gorden, Mark Uhlik, Jeremy Graff, Richard Dale Huhn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells

Sub Track

Phamacodynamic Markers

Citation

J Clin Oncol 35, 2017 (suppl 7S; abstract 33)

DOI

10.1200/JCO.2017.35.7_suppl.33

Abstract #

33

Poster Bd #

D6

Abstract Disclosures

Similar Posters

First Author: Emiliano Calvo

First Author: Neil Gildener-Leapman

First Author: Iwona A. Lugowska

First Author: Minesh Patel